Spine device company Surgalign Holdings has priced an underwritten public offering of 25 million shares of its common stock at $1.50 per share, before underwriting discounts and commissions.
Author: Alan Condon
Neurosurgeon Michael McDermott, MD, was appointed chief of neuroscience at the Herbert Wertheim College of Medicine in Miami, where he will lead all clinical and curricular activities.
San Francisco-based Carrum Health has expanded into Nevada through a partnership with Crovetti Orthopaedics and Sports Medicine, a four-physician group in Henderson.
Private equity firms continue to make inroads into the orthopedic industry in 2021.
Four orthopedic surgeons making headlines this week:
Advertisement
Seven notes from device company notes in the past week, including full-year financial reports from Johnson & Johnson and Stryker.
Orthopedic implant manufacturer Exactech plans to accelerate growth initiatives with three new appointees to its board of directors:
A study published in The Spine Journal found that Orthofix's M6-C artificial cervical disc was safe, effective and noninferior to anterior cervical discectomy and fusion for the treatment of cervical disc degeneration.
Commercial payers continue to expand coverage for minimally invasive sacroiliac joint fusion after CMS increased reimbursement for the procedure last year. More device companies are also focusing innovation efforts in the SI joint space.
Augmented reality-assisted spine surgery has continued to be implemented at hospitals in the first month of the year: